Diligent Investors’s Eli Lilly LLY Stock Holding History

Diligent Investors’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$561K	Buy	468 +40	+9%	+$40.9K	0.13%	199
2026 Q1	$394K	Buy	428 +37	+9%	+$37.5K	0.1%	226
2025 Q4	$420K	Sell	391 -57	-13%	-$54.5K	0.1%	215
2025 Q3	$342K	Buy	448 +81	+22%	+$60.3K	0.09%	241
2025 Q2	$286K	Buy	+367	New	+$285K	0.07%	273
2024 Q2	–	Sell	-464	Closed	-$361K	–	344
2024 Q1	$361K	Sell	464 -38	-8%	-$27K	0.09%	229
2023 Q4	$293K	Hold	502	–	–	0.08%	245
2023 Q3	$270K	Hold	502	–	–	0.08%	237
2023 Q2	$235K	Buy	+502	New	+$211K	0.07%	246

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Diligent Investors's LLY Position: Q2 2026 in Review

Diligent Investors increased its Eli Lilly (LLY) stake by 9.3% in Q2 2026, buying an estimated $40.9K and bringing the position to 468 shares worth $561K. The position accounts for 0.13% of the portfolio, ranked #199.

Diligent Investors first reported a position in LLY in Q2 2023 and has held it in 9 quarters since. 1,583 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Diligent Investors held 468 shares of Eli Lilly worth $561K as of Q2 2026.
Diligent Investors bought 40 Eli Lilly shares in Q2 2026, an estimated $40.9K.
Eli Lilly made up 0.13% of Diligent Investors's portfolio in Q2 2026, its #199 holding.
Diligent Investors first reported a position in Eli Lilly in Q2 2023 and has held it in 9 quarters since.
1,583 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Diligent Investors's 13F filing for Q2 2026, filed 24 Jul 2026.